Levitra (Vardenafil)

Vardenafil selectively blocks the phosphodiesterase type 5 enzyme in penile tissue, which prevents the breakdown of cyclic GMP. Higher cyclic GMP levels cause smooth‑muscle relaxation and increased blood flow to the corpus cavernosum, facilitating an erection in response to sexual stimulation.

The appropriate dose of Levitra is determined by a qualified prescriber based on the patient’s health status, concomitant medications, and response to therapy. Patients should follow the dosing instructions provided by their healthcare professional.

Levitra is indicated for use in adult males and is not recommended for women. There is no established safety data for use during pregnancy or lactation, and it should not be used by pregnant or breastfeeding women.

To request Levitra, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Levitra (vardenafil) belongs to the same PDE5 inhibitor class as sildenafil and tadalafil. While all three increase cyclic GMP to facilitate erections, they differ in onset of action, duration, and specific interaction profiles. Vardenafil typically has a rapid onset (30‑60 minutes) and a duration of about 4‑5 hours.

Levitra should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct heat, and store it out of reach of children.

Levitra is supplied as a buccal formulation. The tablet is placed against the inner cheek and allowed to dissolve, after which the patient may swallow any remaining residue. Administration should occur prior to anticipated sexual activity, as directed by a healthcare professional.

The most serious risks include priapism (a prolonged erection lasting more than four hours), sudden loss of vision, sudden loss of hearing, and severe hypotension, especially when combined with nitrates or other vasodilators. Patients should seek immediate medical attention if any of these events occur.

Levitra should not be used by individuals taking nitrates, those with severe cardiovascular disease such as recent myocardial infarction, uncontrolled hypertension or hypotension, patients with known hypersensitivity to vardenafil, or anyone for whom sexual activity is contraindicated.